LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1/2 pathway
about
LGI proteins in the nervous system.Loss of zebrafish lgi1b leads to hydrocephalus and sensitization to pentylenetetrazol induced seizure-like behavior.The temporal and spatial expression pattern of the LGI1 epilepsy predisposition gene during mouse embryonic cranial development.Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain.Alterations in Barrett's-related adenocarcinomas: a proteomic approach.Inactivation of LGI1 expression accompanies early stage hyperplasia of prostate epithelium in the TRAMP murine model of prostate cancer.Reexpression of LGI1 in glioma cells results in dysregulation of genes implicated in the canonical axon guidance pathway.Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitabilityA computational model of the LGI1 protein suggests a common binding site for ADAM proteins.Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case seriesEctopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection.Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1.Pro-apoptotic effects of rHSG on C6 glioma cells.Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxelGlobal characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer.uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer.Antiproliferative Activity of Triterpene Glycoside Nutrient from Monk Fruit in Colorectal Cancer and Throat CancerTFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions.Epilepsy-aphasia syndromes.Somatic alterations in brain tumors.Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease.Downregulation of LGI1 promotes tumor metastasis in esophageal squamous cell carcinoma.Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro.Identification of miR-30d as a novel prognostic maker of prostate cancer.Expressions of matrix metalloproteinase-7 and matrix metalloproteinase-14 associated with the activation of extracellular signal-regulated kinase1/2 in human brain gliomas of different pathological grades.Activated PKCalpha/ERK1/2 signaling inhibits tamoxifen-induced apoptosis in C6 cells.Arrested glutamatergic synapse development in human partial epilepsy.Deficiency of very large G-protein-coupled receptor-1 is a risk factor of tumor-related epilepsy: a whole transcriptome sequencing analysis.Epilepsy gene LGI1 regulates postnatal developmental remodeling of retinogeniculate synapses.Expression of LGI1 Impairs Proliferation and Survival of HeLa Cells.Give PEAF a chance.Identification of a new JME gene implicates reduced apoptotic neuronal death as a mechanism of epileptogenesis.PDGFR inhibition mediated intracellular signalling in C6 glioma growth and migration: role of ERK and ROCK pathway.Expression of RINT1 predicts seizure occurrence and outcomes in patients with low-grade gliomas.The LGI1/epitempin gene encodes two protein isoforms differentially expressed in human brain.Matrix metalloproteinase-1 (MMP-1) expression in rat spinal cord injury model.
P2860
Q26998200-5862F53C-D1D9-4BE6-BE58-AE6FA9688FEAQ30473220-E2C5427C-EBD5-4F20-BBC2-2F29B87DCD8DQ30475064-D47B5F9E-2C01-4984-839E-E67B8A8537BFQ31148056-8BCC7A71-DF30-4763-8789-6370440D1C0CQ33305454-D08A7C59-93F1-4265-87AC-C0618F5CF283Q33625549-E4AC79B3-7655-42EF-B0BC-61C71B1557F3Q33653166-8A080A46-66FF-4470-8486-684CD8DE0BF8Q33773677-BBD87E95-10DD-4035-BDA2-9B35787ACF1BQ33867620-9C40410F-B08A-4AF7-B5AC-8CC5EA05C72FQ34122865-1912B9A7-B4D0-4B22-BB22-F7C662B94C69Q35585299-A5A7950A-3E77-451C-B620-52E1B2D7C6C2Q35800580-E94AABC5-BCD7-4056-9F5C-84D4932F9A48Q36124303-D5739284-C1B7-4BBB-BD67-0AE47245C953Q36521792-ADE00DB6-7E3E-4D28-BD15-9F376D018D2CQ36926842-4DBF496D-24DA-4CB6-BD5F-EEAAA3BFFB9AQ36955412-0C4A152A-565B-4922-BB23-AA759E749271Q37043566-951380BA-A554-45C8-9BBE-61D221B19279Q37045159-14CCA09E-8956-4273-9591-F636D737E04FQ37294488-6F85F345-6C56-47B6-B1C9-5DCD1EE9EFE4Q37507958-77C8342F-0C01-433F-B38E-138E13699A64Q37601750-E4AB997B-8DEF-4134-95DE-08F0AFCE7B4FQ38316836-860749CC-2B20-4524-A60B-82325F4F9AFAQ39025741-6E08EB0C-5D83-4C8D-8EDA-4030CE78FC8FQ39201247-B81857F2-E3E9-4F81-81B7-7CE99C120730Q39227897-2479C7E4-AE5F-436D-AC32-BB04F9D47425Q39661103-BB9158F3-1DBE-44B1-9426-61AA40CD7991Q39835091-AEE1EC1D-2953-42A7-9BA5-C524A06DC0D0Q41131473-920C86C7-6E2A-44DE-AE22-47241CE7494AQ41685604-FADFFE14-B6C8-4734-8BC3-80986F4F013BQ41770057-8BB37A4C-8D3B-445C-BB7D-C91511C9293EQ42138210-5A83A8CD-03E1-4321-9E9A-419182F8994FQ42176326-172208FF-F604-46C0-A63E-43155AE87DD6Q42921596-CA4E920C-4E54-4463-B129-9717867FDA4CQ47588695-F5B6809E-31E0-4278-91E7-9E222AF4477CQ48489951-0C5B0DE4-3099-4012-B7C1-10446E3AA9F0Q48492168-E8C58EC0-6ECA-4D31-AAB3-8C5ED6005D73Q48630418-5AFB9443-474D-4057-8087-744826038320
P2860
LGI1, a putative tumor metastasis suppressor gene, controls in vitro invasiveness and expression of matrix metalloproteinases in glioma cells through the ERK1/2 pathway
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
LGI1, a putative tumor metasta ...... lls through the ERK1/2 pathway
@ast
LGI1, a putative tumor metasta ...... lls through the ERK1/2 pathway
@en
LGI1, a putative tumor metasta ...... lls through the ERK1/2 pathway
@nl
type
label
LGI1, a putative tumor metasta ...... lls through the ERK1/2 pathway
@ast
LGI1, a putative tumor metasta ...... lls through the ERK1/2 pathway
@en
LGI1, a putative tumor metasta ...... lls through the ERK1/2 pathway
@nl
prefLabel
LGI1, a putative tumor metasta ...... lls through the ERK1/2 pathway
@ast
LGI1, a putative tumor metasta ...... lls through the ERK1/2 pathway
@en
LGI1, a putative tumor metasta ...... lls through the ERK1/2 pathway
@nl
P2860
P3181
P356
P1476
LGI1, a putative tumor metasta ...... lls through the ERK1/2 pathway
@en
P2093
Chitta S Kasyapa
Padmaja Kunapuli
P2860
P304
23151-23157
P3181
P356
10.1074/JBC.M314192200
P407
P577
2004-03-26T00:00:00Z